中国中医药现代远程教育2025,Vol.23Issue(1) :172-174.DOI:10.3969/j.issn.1672-2779.2025.01.054

近10年白术内酯药理作用研究进展

Research Progress on Pharmacological Effects of Atractylenolides from Atractylodes Macrocephala in Recent Ten Years

李天乐 王正娇 李亚玉 姜兆烨 曹迪
中国中医药现代远程教育2025,Vol.23Issue(1) :172-174.DOI:10.3969/j.issn.1672-2779.2025.01.054

近10年白术内酯药理作用研究进展

Research Progress on Pharmacological Effects of Atractylenolides from Atractylodes Macrocephala in Recent Ten Years

李天乐 1王正娇 1李亚玉 1姜兆烨 1曹迪1
扫码查看

作者信息

  • 1. 皖南医学院药学院,安徽芜湖 241001
  • 折叠

摘要

白术是一味传统的中药材,首载于《神农本草经》,具有悠久的药用历史以及丰厚的药用价值.白术中所含的内酯类成分与白术的药效有着巨大的联系,特别是对恶性肿瘤、神经元凋亡、肠胃炎症反应、肝纤维化等疾病的治疗,有着十分显著的效果.文章对近10年内白术内酯的化学结构及相关药理研究进行整理归纳,发现白术内酯Ⅰ、白术内酯Ⅱ、白术内酯Ⅲ为研究最多、活性最为显著的白术内酯类成分.白术内酯类成分的研究与开发,为阿尔茨海默病、恶性肿瘤等疑难杂症的治疗提供了新策略.

Abstract

Rhizoma macrocephala,as a traditional Chinese medicine,was first recorded in Shennong Classic of Materia Medica.It has a long history of medicinal use and rich medicinal value.Based on relevant research,it was found that atractylenolides contained in Rhizoma macrocephala,have a great relationship with the medicinal effects including malignant tumors,neuronal apoptosis,gastroin-testinal inflammatory,liver fibrosis,and other diseases.In this study,the chemical structure and pharmacological studies of atractyle-nolides contained in Rhizoma macrocephala were summarized.Atractylenolide Ⅰ,atractylenolide Ⅱ,and atractylenolide Ⅲ were fre-quently studied and identified as active components.The investigation of atractylenolides contained in Rhizoma macrocephala pro-vides new strategies for the treatment of intractable diseases such as Alzheimer's disease and malignant tumors.

关键词

白术内酯/药理作用/综述

Key words

atractylenolides/pharmacological effect/review

引用本文复制引用

出版年

2025
中国中医药现代远程教育
世中联(北京)远程教育科技发展中心

中国中医药现代远程教育

影响因子:0.531
ISSN:1672-2779
段落导航相关论文